The ROE as of December 2024 (TTM) for Cocrystal Pharma, Inc. (COCP) is -94.62%

According to Cocrystal Pharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -94.62%. This represents a change of 263.78% compared to the average of -26.01% of the last 4 quarters.

Cocrystal Pharma, Inc. (COCP) Historical ROE (quarterly & annually)

How has COCP ROE performed in the past?

The mean historical ROE of Cocrystal Pharma, Inc. over the last ten years is -56.90%. The current -94.62% ROE has changed 66.30% with respect to the historical average. Over the past ten years (40 quarters), COCP's ROE was at its highest in in the December 2017 quarter at 4.93%. The ROE was at its lowest in in the December 2019 quarter at -186.11%.

Cocrystal Pharma, Inc. (COCP) ROE by Quarter and Year

Discovering the peaks and valleys of Cocrystal Pharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cocrystal Pharma, Inc. (COCP) Average ROE

How has COCP ROE performed in the past?

The current ROE of Cocrystal Pharma, Inc. (COCP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cocrystal Pharma, Inc. (COCP) ROE vs. Peers

How is COCP’s ROE compared to its peers?

Cocrystal Pharma, Inc.’s ROE is less than ZIVO Bioscience, Inc. (618.61%), greater than RenovoRx, Inc. (-242.57%), greater than Tempest Therapeutics, Inc. (-187.44%), greater than Ikena Oncology, Inc. (-39.59%), greater than Catalyst Biosciences, Inc. (-63.14%), greater than Moleculin Biotech, Inc. (-165.56%), greater than Pulmatrix, Inc. (-63.07%), less than Cyclacel Pharmaceuticals, Inc. (2.92%), less than Akari Therapeutics, Plc (550.78%), greater than Quoin Pharmaceuticals, Ltd. (-126.19%), greater than Blue Water Vaccines, Inc. (-126.11%), greater than PaxMedica, Inc. Common Stock (-3167.06%), greater than Revelation Biosciences, Inc. (-311.33%), greater than Hillstream BioPharma, Inc. (-172.28%), less than Onconova Therapeutics, Inc. (619.75%), less than Bio-Path Holdings, Inc. (2.62%), greater than Allarity Therapeutics, Inc. (-328.22%), less than Kiromic BioPharma, Inc. (327.18%), greater than Virax Biolabs Group Limited (-115.10%), greater than Biodexa Pharmaceuticals Plc (-101.74%),

Build a custom stock screener for Cocrystal Pharma, Inc. (COCP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cocrystal Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cocrystal Pharma, Inc. (COCP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cocrystal Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.